Advanced in-vitro, analytical and translational research platforms delivering reproducible, decision-ready insights.
Delivering cutting-edge cellular analyses to accelerate drug discovery, toxicological safety, and biomedical research, our cytotoxicity and viability assay suite combines sensitivity, scalability, and mechanistic depth.
Accelerate your research and drug development pipelines with our advanced cell proliferation and cell cycle analysis services. We specialize in delivering accurate, mechanistic insights into how cells grow, divide, and regulate their cycle, providing critical data for oncology, regenerative medicine, and basic biological research.
Understanding regulated cell death is fundamental for innovative drug development, disease modeling, and toxicological safety assessment. Our comprehensive suite of assays accurately detects and quantifies diverse cell death pathways—apoptosis, autophagy, ferroptosis, pyroptosis, and necroptosis—empowering clients with mechanistic insights critical to advancing therapeutics and safety evaluation.
Unlock the dynamics of cell motility and adhesion with our expertly designed assays, essential for cancer metastasis research, tissue engineering, and immunology. Our robust platforms quantify how cells migrate, invade extracellular matrices, and adhere to biologically relevant substrates—translating complex cellular behaviors into actionable data.
Discover how cells sense, generate, and respond to mechanical forces through our cutting-edge mechanosensing and force transduction assay platforms. These powerful techniques provide essential insights into cellular contractility, mechanotransduction pathways, and the physical properties of the cellular microenvironment—vital for understanding development, cancer progression, tissue remodeling, and fibrosis.
Unlock the power of three-dimensional (3D) cell culture, organoids, and microphysiological systems designed to replicate human tissue complexity and function with high fidelity. These innovative platforms elevate drug discovery, toxicology, and disease modeling by providing insights that traditional 2D cultures cannot.
Elevate your research with our state-of-the-art high-content imaging platforms that combine multiplexed fluorescent assays, deep morphological profiling, and sophisticated AI to decode complex cellular phenotypes at scale.
Accelerate your genomic and transcriptomic research projects with our comprehensive nucleic acid analysis portfolio. From pristine DNA/RNA purification to cutting-edge gene editing validation, our customizable workflows and state-of-the-art technologies ensure reproducibility, sensitivity, and regulatory compliance—empowering discovery, translational research, and clinical validation.
Our protein and enzyme characterization suite offers a comprehensive array of cutting-edge analytical techniques essential for the detailed understanding, development, and quality control of biologics and enzymes across discovery and clinical development.
Our comprehensive cell-based and mechanistic molecular assay platforms enable detailed functional analyses of gene regulation, cellular signaling, and response dynamics pivotal for drug discovery and translational research. Harnessing a diverse toolkit that spans reporter gene systems, pathway-specific monitoring, advanced gene delivery, and single-cell genomics, we deliver insights that transform basic biological understanding into therapeutic innovation.
Our advanced analytical and synthetic technology platforms combine innovative cell-free transcription/translation, precision biosensors, cutting-edge spectroscopy, and AI-powered analytics to provide unparalleled insights into biological systems, molecular functions, and synthetic gene circuits.
Biopharmaceutical product development demands rigorous adherence to regulatory frameworks encompassing Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP), and Good Clinical Practice (GCP), collectively known as GxP.
Comprehensive Microbial Detection and Identification. State-of-the-art microbial identification integrates classical microbiology with innovative molecular approaches to achieve high sensitivity, specificity, and speed.
Our antimicrobial efficacy and biocidal testing services deliver robust, standardized evaluation of antimicrobial products, disinfectants, and surface treatments. Designed to meet global regulatory standards, these assays provide accurate, reproducible data critical for product development, quality control, and compliance.
Microbial enzymes—proteases, lipases, cellulases, and amylases—are pivotal in industrial biotechnology and environmental applications. Advanced screening combines classical plate-based assays with high-throughput quantitative techniques.
Explore complex interactions between host cells, microbial communities, and their environments using our physiologically relevant and sensitive assay platforms. These models are indispensable for drug development, microbiome studies, infectious disease research, and environmental safety.
Field-Capable Isothermal Nucleic Acid Amplification. Innovations in rapid, onsite pathogen detection leverage isothermal amplification technologies adaptable to resource-limited settings without thermal cyclers.
Accurate assessment of cytotoxicity is foundational to evaluating the safety profile of compounds, materials, and formulations intended for human use. Our sophisticated cytotoxicity testing portfolio combines multiple complementary assays to deliver detailed insights into cell viability, metabolic function, membrane integrity, apoptosis, and oxidative stress.
Classical Genotoxicity and Mutagenicity Assays. Foundational assays remain essential for initial safety evaluations of chemicals, pharmaceuticals, and environmental agents.
Our organ-specific toxicity platforms combine advanced in vitro models, including organ-on-chip technologies and stem cell-derived organoids, to provide high-fidelity, human-relevant data for assessing toxic effects on critical organ systems. These models enhance prediction accuracy, reduce reliance on animal testing, and accelerate regulatory decision-making.
Embryotoxicity and Stem Cell Fate Assays. Modern developmental toxicity testing increasingly utilizes pluripotent stem cell-based systems to model early embryogenesis and predict teratogenic effects.
Our immunotoxicity and effector response platforms offer comprehensive, mechanistic insights into immune cell modulation, cytokine dynamics, and antibody effector functions crucial for the development and safety evaluation of immunomodulatory therapeutics, vaccines, and biologics.
Stability and Degradation Characterization. Accurate assessment of biopharmaceutical stability under various stress conditions forms the foundation for product development and regulatory compliance.
At the forefront of modern toxicology, our New Approach Methodologies (NAM) leverage advanced in vitro models, computational tools, and multi-omics integration to provide predictive, human-relevant safety and efficacy assessments.
